Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Outokumpu Q3'26 preview: Differences between continents

OUT1V06.11.2026 klo 17.00
Iikka NumminenCommunity Manager
Discuss

Automatic translation from Finnish. Give feedback in the Inderes forum.

Outokumpu's Q3 adjusted EBITDA was EUR 101 million, which was broadly in line with expectations. Revenue was EUR 1,555 million. Stainless steel deliveries decreased by 7% quarter-on-quarter as demand weakened in Europe. However, the Americas business delivered its best earnings in three years. A much weaker-than-expected outlook overshadowed the earnings: Q4'26 adjusted EBITDA is estimated to be at the same level as the EUR 10 million reported in Q4'25. Outokumpu CEO Kati ter Horst comments on the earnings in a video. Topics: (00:00) Outokumpu's Q3 performance (00:41) Americas was strong (01:33) Europe's earnings were weak (02:49) Potential structural changes in Europe? (04:06) Weak customer segments in Europe (05:49) South African ferrochrome production is back on its feet thanks to subsidies (07:38) Guidance points to a weak Q4

Stay up to date
Company management interviews

Upcoming webcasts

Recent videos

Outokumpu Q3'26 preview: Differences between continents
06.11.2026 klo 17.00 Outokumpu
Optomed Q3'26: Earnings improved and costs are decreasing
06.11.2026 klo 16.59 Optomed
Outokumpu, Webcast, Q3'26
06.11.2026 klo 14.30 Outokumpu
Lamor Q3'26 preview: Earnings sank below the surface
06.11.2026 klo 14.29 Lamor
Ascelia Pharma – Presentation of Q3 2026 results
06.11.2026 klo 12.00 Ascelia Pharma
View all videos